Software-based quantitative assessment of ablation margins: a new standard for liver tumour ablation
- PMID: 40090345
- DOI: 10.1016/S2468-1253(25)00061-5
Software-based quantitative assessment of ablation margins: a new standard for liver tumour ablation
Conflict of interest statement
I am a principal investigator for the PROMETHEUS study, which is supported by funding from the Dutch Cancer Society (2020-I/12873), and the IMAGIO project, which is supported by funding from the European Union (HORIZON-JU-IHI-2022–01–02). I have also received payment or honoraria for presentations from Philips Medical Systems, paid to the Leiden University Medical Center.
Comment on
-
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial.Lancet Gastroenterol Hepatol. 2025 May;10(5):442-451. doi: 10.1016/S2468-1253(25)00024-X. Epub 2025 Mar 13. Lancet Gastroenterol Hepatol. 2025. PMID: 40090348 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
